Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Pacira Pharmaceuticals, Inc.”

56 pharma patents match "Pacira Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 56
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 56 pharmaceutical patents matching "Pacira Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

56 results for “Pacira Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 11452691

    Compositions of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  2. US 11426348

    Compositions of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  3. US 11357727

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  4. US 11311486

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  5. US 11304904

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  6. US 11278494

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  7. US 11185506

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  8. US 11179336

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  9. US 11040011

    Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

    Pacira Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  10. US 11033495

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  11. US 10729651

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  12. US 10709665

    Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

    Pacira Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  13. US 10675245

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  14. US 10617642

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  15. US 10610486

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  16. US 10398648

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  17. US 10123974

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  18. US 10045941

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  19. US 10028911

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Pacira Pharmaceuticals, Inc. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  20. US 9974744

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  21. US 9808424

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  22. US 9770414

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Pacira Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  23. US 9757336

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  24. US 9737483

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.